Exforge Generic Deal Is Clear Antitrust Violation, Court Told
A proposed class of drug buyers told a New York federal court Wednesday that an agreement between Novartis Pharmaceuticals Corp. and Par Pharmaceutical Inc. that allegedly delayed the launch of a...To view the full article, register now.
Already a subscriber? Click here to view full article